Evidence on ergogenic action of glucocorticoids as a doping agent risk.
Systemic administration of glucocorticoids (GCs) is banned by the World Anti-Doping Agency (WADA) during competition. Few studies have examined the effects of GCs on exercise performance, but increasing evidence has shown that short-term GC intake enhances performance in animals and humans. However, there are many health risks associated with GC use. Based on the available evidence, as presented in this article, I conclude that GCs are doping agents and should remain on the WADA's list of banned products. Because of the complexity of GCs, however, determining the boundaries between their medical use and abuse (eg, in sports) is a constant challenge for the WADA.
Duclos
Martine
M
Department of Sport Medicine and Functional Explorations, University-Hospital (CHU), Hôpital G. Montpied, Clermont-Ferrand, France. mduclos@chu-clermontferrand.fr
D000818:Animals; D054874:Athletic Performance; D004300:Doping in Sports / Q000379:methods* / Q000517:prevention & control; D005938:Glucocorticoids / Q000008:administration & dosage* / Q000009:adverse effects / Q000032:analysis; D006801:Humans; D015813:Substance Abuse Detection
D005938:Glucocorticoids